Ming Hsieh
Net Worth

Last updated:

What is Ming Hsieh net worth?

The estimated net worth of Mr. Ming Hsieh is at least $22,894,219 as of 25 Nov 2024. He owns shares worth $15,179,046 as insider, has earned $5,483,173 from insider trading and has received compensation worth at least $2,232,000 in Fulgent Genetics, Inc..

What is the salary of Ming Hsieh?

Mr. Ming Hsieh salary is $248,000 per year as Chairman, Chief Executive Officer & Pres in Fulgent Genetics, Inc..

How old is Ming Hsieh?

Mr. Ming Hsieh is 69 years old, born in 1956.

What stocks does Ming Hsieh currently own?

As insider, Mr. Ming Hsieh owns shares in one company:

Company Title Shares Price per share Total value
Fulgent Genetics, Inc. (FLGT) Chairman, Chief Executive Officer & Pres 703,711 $21.57 $15,179,046

What does Fulgent Genetics, Inc. do?

Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions; solid tumor molecular profiling for somatic cancer testing; rapid whole genome testing for children in NICU and PICU; newborn genetic analysis panel; single front-line test to detect ataxia-related variants and repeat expansions through sequencing; picture genetics, a patient-initiated genetic testing; whole exome and clinical exome panel tests; whole genome, mutation, and repeat expansion testing services, as well as research service tests. It also provides next generation sequencing and reverse transcription polymerase chain reaction-based tests, as well as antigen-based diagnostic tests for the detection of SARS-CoV-2. In addition, the company offers flow cytometry, a cell analysis technique providing diagnosis, prognosis, and monitoring of malignancies; fluorescence in-situ hybridization for detecting and locating a specific DNA sequence on a chromosome; immunohistochemistry, an imaging technique used to visualize antigens in cells; cytogenetics, which analyzes the chromosome set for numerical and structural abnormalities; and molecular testing that includes hematopoietic and solid tumor molecular assays. The company serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. Fulgent Genetics has strategic partnership with Helio Health, Inc. to commercialize blood-based early cancer detection tests. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.

FLGT logo
FLGT
Fulgent Genetics, Inc.
$21.57

Ming Hsieh insider trading

Fulgent Genetics, Inc.

Mr. Ming Hsieh has made 3 insider trades between 2016-2024, according to the Form 4 filled with the SEC. Most recently he sold 2,227 units of FLGT stock worth $40,663 on 25 Nov 2024.

The largest trade he's ever made was exercising 4,618,421 units of FLGT stock on 13 May 2016. As of 25 Nov 2024 he still owns at least 703,711 units of FLGT stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 2,227 $18.26 $40,663
Sale
Common Stock 2,313 $22.83 $52,813
Purchase
Common Stock 8,739 $4.95 $43,241
Purchase
Common Stock 10,880 N/A N/A
Purchase
Common Stock 10,000 $3.36 $33,610
Purchase
Common Stock 1,000 $3.6 $3,604
Purchase
Common Stock 1,599 $3.13 $4,997
Purchase
Common Stock 7,259 $3.28 $23,810
Purchase
Common Stock 12,291 $3.16 $38,864
Purchase
Common Stock 1,905 $3.22 $6,136
Purchase
Common Stock 300 $3.28 $985
Purchase
Common Stock 2,800 $3.35 $9,374
Purchase
Common Stock 7,704 $3.28 $25,269
Purchase
Common Stock 9,385 $3.35 $31,402
Purchase
Common Stock 11,520 $3.48 $40,032
Purchase
Common Stock 12,700 $5.35 $67,945
Purchase
Common Stock 7,300 $5.11 $37,281
Purchase
Common Stock 15,000 $5.01 $75,195
Purchase
Common Stock 15,000 $5.01 $75,195
Purchase
Issuer Common Stock 1,000,000 $9 $9,000,000
Sale
Predecessor Class D-1 Preferred Units 4,618,421 $1.17 $5,389,697

Fulgent Genetics key executives

Fulgent Genetics, Inc. executives and other stock owners filed with the SEC:

  • Dr. Han Lin Gao FACMG, M.D., Ph.D., D.A.B.M.G., F.A.C.M.G. (58) Chief Scientific Officer & Laboratory Director
  • Mr. Jian Xie (59) Chief Operating Officer
  • Mr. Ming Hsieh (69) Chairman, Chief Executive Officer & Pres
  • Mr. Paul Kim (58) Chief Financial Officer